Viking Therapeutics (VKTX) Tops Q2 EPS by 6c
Viking Therapeutics (NASDAQ: VKTX) reported Q2 EPS of ($0.20), $0.06 better than the analyst estimate of ($0.26).
For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.
Viking Therapeutics (NASDAQ: VKTX) reported Q2 EPS of ($0.20), $0.06 better than the analyst estimate of ($0.26).
For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.